Section/Topic |
# |
Checklist item |
Reported on page # |
Risk of bias across studies |
15 |
Specify any assessment of risk of bias that may affect the cumulative evidence (e.g. publication bias, selective reporting within studies) |
Yes |
Additional analyses |
16 |
Describe methods of additional analyses (e.g. sensitivity or subgroup analyses, meta‐regression), if done, indicating which were prespecified |
Yes |
RESULTS |
|
Study selection |
17 |
Give numbers of studies screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram |
Yes. In the text ‐ also "Characteristics of excluded studies" |
Study characteristics |
18 |
For each study, present characteristics for which data were extracted (e.g. study size, PICOS, follow‐up period) and provide the citations |
Yes |
Risk of bias within studies |
19 |
Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12) |
Additional Tables 3, 4; Appendices 4, 5 |
Results of individual studies |
20 |
For all outcomes considered (benefits or harms), present, for each study, the following: (a) simple summary data for each intervention group, and (b) effect estimates and confidence intervals, ideally with a forest plot |
Tables of "Characteristics of included studies" |
Synthesis of results |
21 |
Present results of each meta‐analysis done, including confidence intervals and measures of consistency |
N/A |
Risk of bias across studies |
22 |
Present results of any assessment of risk of bias across studies (see Item 15) |
Summary of findings tables |
Additional analysis |
23 |
Give results of additional analyses, if done (e.g. sensitivity or subgroup analyses, meta‐regression [see Item 16]) |
Tables 6 to 10 |
DISCUSSION |
|
Summary of evidence |
24 |
Summarise the main findings including strength of the evidence for each main outcome; consider their relevance to key groups (e.g. healthcare providers, users and policy makers) |
Yes |
Limitations |
25 |
Discuss limitations at study and outcome levels (e.g. risk of bias) and at review level (e.g. incomplete retrieval of identified research, reporting bias) |
Yes |
Conclusions |
26 |
Provide a general interpretation of the results in the context of other evidence, and implications for future research |
Yes |
FUNDING |
|
Funding |
27 |
Describe sources of funding for the systematic review and other support (e.g. supply of data); the role of funders for the systematic review |
Yes |